What side effects are associated with this type of intervention?

Common treatments for Autism Spectrum Disorder (ASD) include behavioral and educational interventions, which generally have minimal side effects but require significant time and effort from both children and caregivers. Complementary and alternative medicine (CAM) therapies, such as dietary supplements and special diets, can have side effects like nutritional deficiencies and should be used cautiously. Specific treatments like secretin and gluten-free casein-free diets are not recommended due to lack of efficacy and potential risks. Behavioral interventions are generally safe but may cause stress due to their intensive nature.

What prior FDA approvals exist?

The FDA has approved two medications specifically for the treatment of irritability associated with autism spectrum disorder (ASD): risperidone and aripiprazole. These medications are antipsychotics that help manage symptoms such as aggression, self-injury, and severe tantrums. While the context does not provide specific details on FDA approvals related to the Adapted Autism Spectrum Disorder Assessment Measure in a telehealth setting, it is important to note that these medications are part of the broader pharmacological approach to managing ASD symptoms.

What other types of research exist?

Promising alternatives to the Adapted Autism Spectrum Disorder Assessment Measure for telehealth settings include the Autism Diagnostic Interview-Revised (ADI-R) administered via telephone, and telehealth-delivered Cognitive Behavioral Therapy for Insomnia (CBT-I) adapted for autism patients. These tools have shown reliability and feasibility in remote formats, making them suitable for telehealth assessments and interventions in 2024.

← Back to Search

Behavioral Intervention

Telehealth Autism Assessment for Adults

N/A

Waitlist Available

Led By Brianna Lewis, PhD

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-60 years old

Be between 18 and 65 years old

Must not have

Non-fluent English speaker

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new way to diagnose Autism Spectrum Disorder using online video calls. It aims to help people who can't easily visit a doctor in person by providing a reliable and accurate remote assessment.

Who is the study for?

This trial is for adults aged 18-60 who have or may have Autism Spectrum Disorder. Participants must be fluent in English, able to read and write in English, and have access to a personal computer with video, microphone, and speakers.

What is being tested?

The study is testing the effectiveness of an adapted version of ADOS-2 Module 4 (a diagnostic tool for autism) when used over telehealth services compared to its standard use in person.

What are the potential side effects?

There are no direct physical side effects expected from participating in this trial as it involves assessment procedures rather than medical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 60 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am not fluent in English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Concurrent validity

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Telehealth assessmentExperimental Treatment1 Intervention

Group II: Standardized assessmentActive Control1 Intervention

0 / 2Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Common treatments for Autism Spectrum Disorder (ASD) often involve behavioral and educational interventions that focus on individualized programming, high staff-to-student ratios, and family involvement. These treatments aim to improve communication, social skills, and adaptive functioning through structured and predictable environments. Techniques such as the Picture Exchange Communication System (PECS) and augmentative communication strategies help nonverbal children initiate communication, reducing frustration. The emphasis on early and intensive intervention is crucial as it can lead to better outcomes. In telehealth settings, these treatments can be adapted to ensure continuity of care, making it easier for families to access specialized services and support, which is essential for the ongoing development and well-being of children with ASD.

Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials.Outcomes and moderators of Early Start Denver Model intervention in young children with autism spectrum disorder delivered in a mixed individual and group setting.